CHICAGO, April 22, 2015 /PRNewswire-USNewswire/
-- Currently only seven percent of people diagnosed with
pancreatic cancer in the United
States will survive more than five years. More than 4,300
supporters will join the movement to Wage Hope and double
pancreatic cancer survival by 2020 at #PurpleStride Chicago. The
timed run and awareness walk will take place on Saturday, May 2 to raise awareness and funds to
support the mission of the Pancreatic Cancer Action Network to
advance research, support patients and create hope.
To learn more and register visit
purplestride.org.
The day will honor pancreatic cancer survivors like Michael Weber who was diagnosed in August 2014. Since then, Michael has been
utilizing the Pancreatic Cancer Action Network to identify
intuitions where he can receive treatments while traveling, as well
as current information on the disease, from clinical trials, to
diet and nutrition and symptom management. Michael will be
attending PurpleStride with his team "Purple for Poppie" behind
him, including his wife of 49 years, his three daughters, and his
grandchildren who will be wearing purple for their "Poppie."
Participants will also be striding as a tribute to those who
have passed away from the disease like Karen Steckbauer who lost her battle with
pancreatic cancer at the age of 33 more than 25 years ago. Karen's
daughter Kelli Steckbauer, who was
only eight years old when she lost her mother, has since joined the
fight against pancreatic cancer. Kelli will be joined by friends
and family in honor of her mother on event day.
"PurpleStride Chicago is an uplifting day meant to create hope
and encouragement for people who've been affected by pancreatic
cancer," said Steckbauer. "Funds raised help provide personalized
support for patients and support research grants and advocacy
efforts to increase federal pancreatic cancer research
funding."
PurpleStride Chicago
event details:
- Saturday, May 2, 2015 at Montrose
Harbor
- Registration begins at 7:00 a.m.
and the event will start at 8:30
a.m.
- 5K timed run or awareness walk
- Family friendly activities throughout the day
- National Silver Sponsors:
This year, it is estimated 48,960 Americans will be diagnosed
with pancreatic cancer and approximately 40,560 will die from the
disease. It is currently the fourth leading cause of cancer death
in the United States. A study by
the Pancreatic Cancer Action Network, published in the journal
Cancer Research, predicts that by 2020
pancreatic cancer will surpass breast and colorectal cancer to
become the second leading cause of cancer-related death in
the United States.
To learn more about the Pancreatic Cancer Action Network and the
Chicago Affiliate, visit pancan.org.
Follow us: www.facebook.com/jointhefight
Watch us: www.youtube.com/StopPancreaticCancer
Tweet us: @pancan & #PurpleStride
Instagram us: @pancan #PurpleStride
About the Pancreatic Cancer Action Network
The
Pancreatic Cancer Action Network is the national organization
creating hope in a comprehensive way through research, patient
support, community outreach and advocacy for a cure. The
organization is leading the way to change outcomes for people
diagnosed with this devastating disease through a bold initiative —
The Vision of Progress: Double the Survival for Pancreatic Cancer
by 2020. Together, we can know, fight and end pancreatic cancer by
intensifying our efforts to heighten awareness, raise funds for
comprehensive private research, and advocate for dedicated federal
research to advance early diagnostics, better treatments and
increase chances of survival.
Contact:
Faith See
Public Relations Manager
Pancreatic Cancer Action Network
Direct: (310)-706-3369
Email: fsee@pancan.org
Related Links:
Register today for PurpleStride Chicago!
Photo - http://photos.prnewswire.com/prnh/20150422/200292
Photo - http://photos.prnewswire.com/prnh/20150422/200290
Photo - http://photos.prnewswire.com/prnh/20150422/200291
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/fight-pancreatic-cancer-at-purplestride-chicago-300070091.html
SOURCE Pancreatic Cancer Action Network